Norway delays decision to ditch AstraZeneca vaccine, warning it could impact J&J rollout

The Norwegian government said it needs more time to decide whether to restart the use of AstraZeneca's COVID-19 vaccine, or permanently remove it from the country's immunization program.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.